Abstract
Herein, we report the first case presentation of paraneoplastic myelofibrosis associated with cancer. Paraneoplastic syndromes occur in some patients with thoracic malignancies; however, myelofibrosis is not commonly seen in non-small cell lung cancer (NSCLC). We report a case of myelofibrosis in a patient with a new diagnosis of NSCLC that resolved after stereotactic ablative radiotherapy (SABR). In conclusion, NSCLC may evoke unexpected systemic effects that resolve with treatment.
Original language | English (US) |
---|---|
Article number | 842620 |
Journal | Frontiers in Oncology |
Volume | 12 |
DOIs | |
State | Published - Feb 24 2022 |
Keywords
- NSCLC
- SAbR
- case
- paraneoplastic
- report
ASJC Scopus subject areas
- Oncology
- Cancer Research